Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1250 MG CK-2017357----2件: 2, 11 💬
2500 MG CK-2017357----2件: 2, 11 💬
3Abatacept injection1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬3件: 11, 46, 107 💬
4Acetaminophen1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬14件: 11, 19, 34, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
5Acetate1件: Acetate---14件: 11, 46, 49, 51, 70, 71, 73, 76, 89, 97, 158, 235, 265, 299 💬
6Acotiamide1件: Acotiamide---2件: 11, 51 💬
7Addition OF rituximab IF recurrence----1件: 11 💬
8ALN-CC5----4件: 11, 62, 66, 109 💬
9ALXN1210----7件: 2, 11, 13, 50, 62, 66, 109 💬
10ALXN1720----1件: 11 💬
11ALXN1830----3件: 11, 35, 61 💬
12ALXN2050----3件: 11, 62, 66 💬
13Amifampridina----1件: 11 💬
14Amifampridina fosfato----2件: 3, 11 💬
15Amifampridine1件: Amifampridine2件: Amifampridine ,
Amifampridine phosphate 💬 		4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 11 💬
16Amifampridine (base) with modified release1件: Amifampridine2件: Amifampridine ,
Amifampridine phosphate 💬 		4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 11 💬
17Amifampridine phosphate1件: Amifampridine2件: Amifampridine ,
Amifampridine phosphate 💬 		4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬3件: 3, 11, 12 💬
18Anito-CEL1件: Anitocabtagene autoleucel---1件: 11 💬
19ANTI-C5 antibody----4件: 11, 14, 62, 109 💬
20ANTI-thymocyte globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
21Apraclonidine HCL 0.5% OPH soln1件: Apraclonidine2件: Apraclonidine hydrochloride ,
Apraclonidine 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 11 💬
22ARGX-113----5件: 11, 14, 35, 53, 63 💬
23Autologous hematopoietic stem cell transplantation----7件: 11, 13, 14, 28, 49, 51, 84 💬
24AZA----4件: 11, 40, 96, 97 💬
25Azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--22件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
26B-peptide-CRM197 conjugate----1件: 11 💬
27B007----3件: 11, 35, 222 💬
28Batoclimab1件: Batoclimab1件: Batoclimab 💬 --2件: 11, 14 💬
29Batoclimab 340 MG SC BI-weekly1件: Batoclimab1件: Batoclimab 💬 --1件: 11 💬
30Batoclimab 340 MG SC weekly1件: Batoclimab1件: Batoclimab 💬 --2件: 11, 14 💬
31Batoclimab 680 MG SC weekly1件: Batoclimab1件: Batoclimab 💬 --1件: 11 💬
32BBR 2778----2件: 11, 13 💬
33Belimumab1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬13件: 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 95, 222, 296 💬
34Bexsero----4件: 11, 13, 62, 222 💬
35Blinatumomab1件: Blinatumomab1件: Blinatumomab 💬 4件: CD19,
CD3D,
CD3E,
CD3G 💬 		13件: B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬3件: 11, 46, 49 💬
36Bortezomib2件: Bortezomib,
Bortezomib D-mannitol		1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬16件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 172, 222, 228, 256, 288, 331 💬
37BU zhong YI QI tang----1件: 11 💬
38CABA-201----3件: 11, 49, 51 💬
39Carmustine1件: Carmustine1件: Carmustine 💬 --5件: 11, 13, 14, 28, 60 💬
40CC-97540----4件: 11, 13, 49, 51 💬
41CD19-bcma targeted CAR-T dose 1----1件: 11 💬
42CD19-bcma targeted CAR-T dose 2----1件: 11 💬
43CD19-directed humanised afucosylated monoclonal antibody----1件: 11 💬
44CD20/BCMA-directed CAR-T cells----3件: 11, 13, 49 💬
45Cellcept1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬5件: 11, 13, 42, 43, 49 💬
46Cellcept 500 MG----1件: 11 💬
47Cellcept 500 MG FILM-coated tablets1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 11 💬
48Cellcept 500 MG tablets1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 11 💬
49Cellcept®500 MG tablets1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 11 💬
50Cemdisiran1件: Cemdisiran---4件: 11, 62, 66, 109 💬
51CFZ533----4件: 11, 46, 49, 53 💬
52Cladribine1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 11, 13, 94 💬
53Cladribine high dose1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 11 💬
54Cladribine LOW dose1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 11 💬
55Cladrybine----1件: 11 💬
56CNP-106----1件: 11 💬
57CT103A cells1件: CT103A---3件: 11, 13, 16 💬
58CV-MG011件: CV-MG01---1件: 11 💬
59Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
60Cyclophosphamide and fludarabine1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--3件: 11, 13, 16 💬
61Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬28件: 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
62Cytarabine1件: Cytarabine2件: Cytarabine ,
Cytarabine hydrochloride 💬 		--7件: 11, 13, 14, 25, 34, 49, 60 💬
63DAS-001----1件: 11 💬
64Decartes-08----1件: 11 💬
65Descartes-08----2件: 11, 49 💬
66Difenidramina cloridrato----3件: 11, 19, 63 💬
67Diphenhydramine hydrochloride1件: Diphenhydramine4件: Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬2件: 11, 49 💬
68DNTH103----2件: 11, 14 💬
69Eculizumab1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 11, 13, 14, 61, 62, 109, 221, 222 💬
70Efalizumab1件: Efalizumab1件: Efalizumab 💬 1件: ITGAL 💬 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬9件: 11, 13, 37, 46, 53, 61, 95, 96, 221 💬
71Efgartigimod----6件: 11, 14, 35, 53, 63, 64 💬
72Efgartigimod + telitacicept (1-week interval) group1件: Telitacicept---1件: 11 💬
73Efgartigimod + telitacicept (2-week interval) group1件: Telitacicept---1件: 11 💬
74Efgartigimod administration----1件: 11 💬
75Efgartigimod alfa1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --6件: 11, 14, 35, 53, 63, 162 💬
76Efgartigimod concentrate FOR solution FOR infusion 20 MG/ML----1件: 11 💬
77Efgartigimod IV----3件: 11, 63, 222 💬
78Efgartigimod IV or efgartigimod PH20 SC----1件: 11 💬
79Efgartigimod PH20 SC----5件: 11, 14, 35, 63, 162 💬
80EN101----1件: 11 💬
81Ephedrine hydrochloride1件: Ephedrine3件: Ephedrine ,
Ephedrine hydrochloride ,
Ephedrine sulfate 💬 		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
82Etomidate1件: Etomidate1件: Etomidate 💬 1件: GABRA 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬2件: 6, 11 💬
83Etoposide1件: Etoposide2件: Etoposide ,
Etoposide phosphate 💬 		--12件: 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
84Famciclovir1件: Famciclovir1件: Famciclovir 💬 --2件: 11, 13 💬
85FC- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109 💬
86Firdapse - 10 MG - compresse - USO orale - blister(ALU/PVC/pvdc) 100 X 1 compresse----2件: 3, 11 💬
87Fludarabine1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬23件: 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
88G-CSF1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬18件: 2, 6, 11, 13, 16, 22, 47, 49, 51, 60, 61, 62, 65, 85, 96, 284, 285, 331 💬
89Galantamine1件: Galantamine2件: Galantamine hydrobromide ,
Galantamine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬2件: 6, 11 💬
90GC012F injection----2件: 11, 49 💬
91Gefurulimab1件: Gefurulimab1件: Gefurulimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11 💬
92Genotype analysis FOR VDR RS1544410, RS2228570, RS731236, and RS7975232 polymorphisms----1件: 11 💬
93GSK1550188----4件: 11, 49, 66, 222 💬
94Hematopoietic stem cell transplantation----13件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
95Hidrocloruro DE efedrina1件: Ephedrine3件: Ephedrine ,
Ephedrine hydrochloride ,
Ephedrine sulfate 💬 		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
96HN2301 injection----2件: 11, 49 💬
97Human normal immunoglobulin1件: Human immunoglobulin G1件: Globulin, immune 💬 --8件: 11, 13, 14, 43, 45, 50, 63, 65 💬
98Humanised VHH-type bispecific antibody against complement component 5 and serum albumin----1件: 11 💬
99IGIV-C----1件: 11 💬
100Immediate treatment with corticosteroids----1件: 11 💬
101Immune globulin----3件: 11, 13, 14 💬
102Immune globulin (human), 10% caprylate/chromatography purified----1件: 11 💬
103Immunoglobulin G----9件: 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
104IMVT-1401----2件: 11, 14 💬
105Inebilizumab1件: Inebilizumab1件: Inebilizumab 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬6件: 11, 13, 46, 49, 51, 300 💬
106Influenza vaccine----6件: 11, 13, 46, 51, 84, 97 💬
107Intravenous immuneglobulin----1件: 11 💬
108Iptacopan1件: Iptacopan2件: Iptacopan ,
Iptacopan hydrochloride 💬 		1件: CFB 💬 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬6件: 11, 61, 62, 66, 109, 222 💬
109IV efgartigimod----1件: 11 💬
110Ivig----8件: 11, 13, 14, 35, 51, 63, 65, 172 💬
111JNJ-80202135----4件: 11, 46, 49, 53 💬
112KYV-101----4件: 11, 13, 50, 51 💬
113Laboratory biomarker analysis----22件: 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
114LCAR-AIO T cells----3件: 11, 13, 49 💬
115Leflunomide1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬13件: 11, 40, 46, 49, 53, 54, 66, 107, 162, 224, 270, 271, 300 💬
116M281----5件: 11, 46, 49, 53, 61 💬
117M281 injection----1件: 11 💬
118Mabthera1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬17件: 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 61, 63, 64, 65, 83, 162, 222 💬
119Magnesium sulfate2件: Magnesium,
Magnesium sulfate		1件: Magnesium sulfate 💬 --3件: 11, 296, 297 💬
120Melphalan1件: Melphalan2件: Melphalan ,
Melphalan hydrochloride 💬 		--19件: 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
121Meningococcal group A oligosaccharides conjugated TO corynebacterium diphtheriae C7 (ß197) M8 (CRM197) protein----1件: 11 💬
122Meningococcal group W oligosaccharides conjugated TO corynebacterium diphtheriae C7 (ß197) M8 (CRM197) protein----1件: 11 💬
123Meningococcal group Y oligosaccharides conjugated TO corynebacterium diphtheriae C7 (Â197) M8 (CRM197) protein----1件: 11 💬
124Menveo----4件: 11, 13, 62, 222 💬
125Mesna----11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
126Mestinon1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬3件: 3, 6, 11 💬
127Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬37件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
128Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
129Metilprdnisolone----1件: 11 💬
130Metilprednisolone----2件: 11, 63 💬
131Monarsen1件: Monarsen---1件: 11 💬
132Monitor1件: Methamidophos---8件: 2, 6, 11, 28, 81, 118, 129, 299 💬
133MUSK-caart----1件: 11 💬
134Mutagrip----2件: 11, 13 💬
135Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬32件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
136Mycophenolic acid1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬8件: 11, 43, 49, 51, 60, 66, 96, 222 💬
137N. meningitidis group C (strain C11) oligosaccharide conjugated TO corynebacterium diphtheriae CRM197 adsorbed ON aluminum hydroxide----1件: 11 💬
138Neostigmine1件: Neostigmine3件: Neostigmine bromide ,
Neostigmine methylsulfate ,
Neostigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 11 💬
139Nipocalimab1件: Nipocalimab1件: Nipocalimab 💬 --6件: 11, 14, 46, 49, 53, 61 💬
140Nipocalimab 1件: Nipocalimab1件: Nipocalimab 💬 --1件: 11 💬
141NMD670----3件: 3, 10, 11 💬
142Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬4件: 11, 13, 46, 49 💬
143Ofatumumab1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬4件: 11, 13, 35, 46 💬
144Outer membrane vesicles (OMV) from neisseria meningitidis group B strain NZ98/254measured AS amount OF total protein containing THE pora P1.4----1件: 11 💬
145Oxaloacetate1件: Oxaloacetic acid---2件: 6, 11 💬
146Paracetamolo----7件: 2, 11, 14, 28, 61, 63, 309 💬
147Peripheral blood stem cell transplantation----12件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
148Phosphate1件: Phosphate ion---13件: 3, 11, 13, 46, 65, 70, 75, 90, 235, 238, 256, 286, 288 💬
149Pixantrone1件: Pixantrone2件: Pixantrone ,
Pixantrone dimaleate 💬 		--2件: 11, 13 💬
150Plasmapheresis----4件: 11, 49, 113, 222 💬
151Plex----1件: 11 💬
152Pozelimab1件: Pozelimab1件: Pozelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 11, 62 💬
153Pozelimab + cemdisiran2件: Cemdisiran,
Pozelimab		1件: Pozelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11 💬
154Prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬38件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
155Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
156Prednisone - azathioprine1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 11 💬
157Prednisone alone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 11, 66 💬
158Privigen1件: Human immunoglobulin G1件: Globulin, immune 💬 --5件: 11, 14, 51, 63, 65 💬
159PRN2246----2件: 11, 13 💬
160Pyridostigmine1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬3件: 3, 11, 51 💬
161Pyridostigmine bromide1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬5件: 3, 6, 11, 51, 256 💬
162Pyridostigmine, prednisone, tacrolimus1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 11 💬
163Pyridostigmine, tacrolimus1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 11 💬
164Rabbit1件: Rabbit---5件: 11, 13, 60, 96, 285 💬
165Raptiva 100 MG/ML powder and solvent FOR solution FOR injection1件: Efalizumab1件: Efalizumab 💬 1件: ITGAL 💬 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬8件: 11, 13, 46, 53, 61, 95, 96, 221 💬
166Ravulizumab1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 2, 11, 13, 50, 62, 66, 109 💬
167RC18 160MG----3件: 11, 13, 66 💬
168RC18 240 MG----2件: 11, 53 💬
169Recombinant neisseria meningitidis group B fhbp fusion protein produced IN E.coli cells BY recombinant DNA technology adsorbed ON aluminium hydroxide----1件: 11 💬
170Recombinant neisseria meningitidis group B nada protein----1件: 11 💬
171Recombinant neisseria meningitidis group B nhba fusion protein----2件: 11, 13 💬
172REGN3918----2件: 11, 62 💬
173Remibrutinib1件: Remibrutinib1件: Remibrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬3件: 11, 13, 53 💬
174Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
175RO 533-3787/F01-06----1件: 11 💬
176RO5333787----2件: 11, 13 💬
177Rozanolixizumab1件: Rozanolixizumab1件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
178RVT-1401----3件: 11, 14, 61 💬
179RVT-1401, HL161BKN, HBM9161----1件: 11 💬
180Salbutamol 4MG tablet1件: Albuterol2件: Albuterol sulfate ,
Albuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
181Salbutamol WZF 4 MG1件: Albuterol2件: Albuterol sulfate ,
Albuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
182SAR442168----2件: 11, 13 💬
183Satralizumab1件: Satralizumab1件: Satralizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬4件: 11, 13, 86, 113 💬
184Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, LOW frequency repeated nerve stimulation----1件: 11 💬
185Serum albumin1件: Albumin human2件: Albumin human ,
Human serum albumin 💬 		--2件: 11, 222 💬
186Sodium chloride1件: Sodium chloride1件: Sodium chloride 💬 --20件: 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 227, 288, 299 💬
187Sodium chloride solution1件: Sodium chloride1件: Sodium chloride 💬 --4件: 11, 13, 51, 228 💬
188Soliris1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬6件: 11, 13, 14, 62, 109, 222 💬
189Standard lymphodepletion regimen----3件: 11, 13, 51 💬
190Steroid drug----3件: 11, 46, 49 💬
191Subcutaneous immunoglobulins----1件: 11 💬
192Sufentanil1件: Sufentanil2件: Sufentanil citrate ,
Sufentanil 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬4件: 11, 22, 70, 280 💬
193Sugammadex1件: Sugammadex1件: Sugammadex sodium 💬 --1件: 11 💬
194Sulfate1件: Sulfate ion1件: Sulfuric acid 💬 --6件: 2, 3, 11, 49, 222, 224 💬
195Syngeneic bone marrow transplantation----3件: 11, 13, 14 💬
196SYS6020 injection----1件: 11 💬
197T-peptide-CRM197 conjugate----1件: 11 💬
198Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬31件: 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
199Tacrolimus capsule1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
200TAK-079----3件: 11, 49, 63 💬
201Telitacicept1件: Telitacicept---11件: 11, 13, 46, 48, 49, 51, 53, 63, 66, 222, 300 💬
202Telitacicept-only group1件: Telitacicept---1件: 11 💬
203Tetanus vaccin----1件: 11 💬
204Thymectomy plus prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 11 💬
205Tocilizumab1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬24件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
206Tocilizumab injectable product1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 11 💬
207Tocilizumab injection1件: Tocilizumab1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 11, 13 💬
208Tofacitinib 5 MG1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬5件: 11, 40, 46, 50, 271 💬
209Tolebrutinib1件: Tolebrutinib1件: Tolebrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬2件: 11, 13 💬
210Tolebrutininb----1件: 11 💬
211Ucar T-cell----3件: 11, 13, 51 💬
212Ucar T-cell group----3件: 11, 49, 61 💬
213UCB76651件: Rozanolixizumab1件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
214Ultomiris1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 2, 11, 13, 50, 62, 66, 109 💬
215Ultomiris 1,100 MG/11 ML1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11 💬
216Universal bcma CAR-T----2件: 11, 13 💬
217Universal CD19 CAR-T----2件: 11, 13 💬
218Uplizna1件: Inebilizumab1件: Inebilizumab 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬3件: 11, 13, 300 💬
219Velamox----1件: 11 💬
220Withdraw ALL immunosuppresants----1件: 11 💬
221YTB323----2件: 11, 49 💬
222Zilbrysq----1件: 11 💬
223Zilucoplan1件: Zilucoplan2件: Zilucoplan sodium ,
Zilucoplan 💬 		1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 11, 62 💬